Omega-3 mixtures
The present invention is directed to mixtures of omega- 3 fatty acids, formulations of these mixtures suitable for use in a variety of dosage forms or food/beverage additives, and uses of these mixtures for preventative or therapeutic health purposes.
1 . A composition comprising a long chain omega-3 fatty acid and a short chain omega-3 fatty acid, wherein the weight ratio of said long chain omega-3 fatty acid to said short chain omega-3 fatty acid is in the range of about 1:2 to about 1:10.
2 . The composition of claim 1 , wherein at least one of said long chain omega-3 fatty acid and said short chain omega-3 fatty acid is emulsified.
3 . The composition of claim 1 , wherein the weight ratio of said long chain omega-3 fatty acid to said short chain omega-3 fatty acid is in the range of about 1:2 to about 1:5.
4 . A composition comprising a first component and a second component, wherein said first component comprises krill oil, and said second component is selected from the group consisting of fish oil, flax oil, chia oil, echium oil, and mixtures thereof.
5 . The composition of claim 4 wherein at least one of said first component and said second component is emulsified.
6 . A composition comprising a first component and a second component, wherein said first component comprises fish oil, and said second component is selected from the group consisting of chia oil, echium oil, and mixtures thereof.
7 . The composition of claim 6 wherein at least one of said first component and said second component is emulsified.
8 . A formulation comprising a first component, a second component, and an excipient, wherein said first component comprises a marine-derived omega-3 containing oil, and said second component comprises a plant-derived omega-3 containing oil.
9 . The formulation of claim 8 , wherein at least one of said first component and said second component is emulsified.
10 . A formulation comprising a first component, a second component, and an excipient, wherein said first component comprises a long chain omega-3 fatty acid, and said second component comprises a short chain omega-3 fatty acid.
11 . The formulation of claim 10 , wherein at least one of said first component and said second component is emulsified.
12 . The formulation of claim 10 , wherein the weight ratio of said long chain omega-3 fatty acid to said short chain omega-3 fatty acid is in the range of about 2:1 to about 1:10.
13 . The formulation of claim 10 , wherein the weight ratio of said long chain omega-3 fatty acid to said short chain omega-3 fatty acid is in the range of about 1:0.8 to about 1:5.
14 . A process for forming a composition comprising mixing at least two omega-3 fatty acids selected from the group consisting eicosapentaenoic acid, docosahexaenoic acid, linolenic acid and stearidonic acid.
15 . The process of claim 14 , further comprising emulsifying at least one omega-3 fatty acid prior to mixing.
16 . A food or beverage comprising the composition of claim 1 .
17 . A food or beverage comprising the composition of claim 4 .
18 . A food or beverage comprising the composition of claim 6 .
19 . A food or beverage comprising the formulation of claim 8 .
20 . A food or beverage comprising the formulation of claim 10 .
21 . A method of increasing absorption of dietary omega-3s in a subject, comprising administering to said subject the composition of claim 1 .
22 . A method of increasing absorption of dietary omega-3s in a subject, comprising administering to said subject the composition of claim 4 .
23 . A method of increasing absorption of dietary omega-3s in a subject, comprising administering to said subject the composition of claim 6 .
24 . A method of increasing absorption of dietary omega-3s in a subject, comprising administering to said subject the formulation of claim 8 .
25 . A method of increasing absorption of dietary omega-3s in a subject, comprising administering to said subject the formulation of claim 10 .
26 . A method of treating a condition selected from the group consisting cardiovascular disease, hypertension, joint disease, mood disorders, depression, cognition-related disorders, attention deficit hyperactivity disorder, and premenstrual syndrome, said method comprising administering to a subject, the composition of claim 1 .
27 . A method of treating a condition selected from the group consisting cardiovascular disease, hypertension, joint disease, mood disorders, depression, cognition-related disorders, attention deficit hyperactivity disorder, and premenstrual syndrome, said method comprising administering to a subject, the composition of claim 4 .
28 . A method of treating a condition selected from the group consisting cardiovascular disease, hypertension, joint disease, mood disorders, depression, cognition-related disorders, attention deficit hyperactivity disorder, and premenstrual syndrome, said method comprising administering to a subject, the composition of claim 6 .
29 . A method of treating a condition selected from the group consisting cardiovascular disease, hypertension, joint disease, mood disorders, depression, cognition-related disorders, attention deficit hyperactivity disorder, and premenstrual syndrome, said method comprising administering to a subject, the formulation of claim 8 .
30 . A method of treating a condition selected from the group consisting cardiovascular disease, hypertension, joint disease, mood disorders, depression, cognition-related disorders, attention deficit hyperactivity disorder, and premenstrual syndrome, said method comprising administering to a subject, the formulation of claim 10 .